Capricor Therapeutics Announces Late-Breaking Presentation of HOPE-3 Phase 3 Results at the American Academy of Neurology 2026 Annual Meeting
Go back to Capricor Therapeutics Announces Late-Breaking Presentation of HOPE-3 Phase 3 Results at the American Academy of Neurology 2026 Annual Meeting| Capricor Therapeutics, Inc. (NASDAQ: CAPR) | Delayed: 28.38 +0.43 (1.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.95 | 52 Week High | $5.40 | |||
| Open | $28.28 | 52 Week Low | $1.88 | |||
| Day High | $29.27 | P/E | N/A | |||
| Day Low | $27.63 | EPS | $0.00 | |||
| Volume | 3,095,680 | |||||
